Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
AKT serine/threonine kinase 1 | 0.311 | 0.962 | 0.98 |
|
disease | 0.500 | None | 0.976 | 1 | 1 | 2002 | 2020 | ||||||||
|
ATM serine/threonine kinase | 0.374 | 0.885 | 5.6E-47 |
|
disease | 0.500 | None | 1.000 | 0 | 1 | 2007 | 2019 | ||||||||
|
BRCA1 associated protein 1 | 0.454 | 0.731 | 0.99 |
|
disease | 0.700 | strong | 0.950 | 0 | 1 | 2010 | 2019 | ||||||||
|
B-Raf proto-oncogene, serine/threonine kinase | 0.319 | 0.846 | 1.00 |
|
disease | 1.000 | None | 0.983 | 56 | 31 | 1986 | 2020 | ||||||||
|
BRCA2 DNA repair associated | 0.379 | 0.846 | 2.4E-25 |
|
disease | 0.500 | None | 0.870 | 0 | 2 | 1996 | 2019 | ||||||||
|
cyclin dependent kinase 4 | 0.412 | 0.808 | 6.3E-02 |
|
disease | 0.700 | strong | 0.961 | 1 | 1 | 1994 | 2020 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
disease | 0.800 | strong | 0.950 | 2 | 4 | 1994 | 2020 | ||||||||
|
checkpoint kinase 2 | 0.460 | 0.808 | 1.2E-24 |
|
disease | 0.150 | None | 0.800 | 0 | 1 | 2004 | 2013 | ||||||||
|
catenin beta 1 | 0.303 | 0.885 | 1.00 |
|
disease | 0.500 | None | 0.986 | 9 | 12 | 1996 | 2020 | ||||||||
|
erb-b2 receptor tyrosine kinase 4 | 0.455 | 0.846 | 1.00 |
|
disease | 0.700 | None | 0.917 | 1 | 6 | 2009 | 2018 | ||||||||
|
fibrillin 1 | 0.417 | 0.846 | 1.00 |
|
disease | 0.100 | None | 0 | 1 | |||||||||||
|
G protein subunit alpha 11 | 0.563 | 0.731 | 0.89 |
|
disease | 0.700 | None | 1.000 | 5 | 1 | 1989 | 2019 | ||||||||
|
G protein subunit alpha q | 0.516 | 0.808 | 0.98 |
|
disease | 0.700 | None | 0.967 | 9 | 1 | 1989 | 2019 | ||||||||
|
HRas proto-oncogene, GTPase | 0.378 | 0.885 | 8.0E-02 |
|
disease | 0.800 | None | 1.000 | 1 | 1 | 1984 | 2018 | ||||||||
|
KIT proto-oncogene, receptor tyrosine kinase | 0.366 | 0.808 | 0.98 |
|
disease | 0.500 | None | 0.967 | 35 | 20 | 1992 | 2020 | ||||||||
|
mitogen-activated protein kinase kinase 1 | 0.439 | 0.846 | 0.90 |
|
disease | 0.700 | None | 1.000 | 11 | 14 | 2003 | 2019 | ||||||||
|
mitogen-activated protein kinase kinase 2 | 0.534 | 0.731 | 0.97 |
|
disease | 0.670 | None | 1.000 | 2 | 5 | 2011 | 2019 | ||||||||
|
NRAS proto-oncogene, GTPase | 0.390 | 0.808 | 0.49 |
|
disease | 0.700 | None | 0.969 | 21 | 10 | 1987 | 2020 | ||||||||
|
partner and localizer of BRCA2 | 0.485 | 0.769 | 3.0E-19 |
|
disease | 0.150 | None | 0.600 | 0 | 1 | 2011 | 2018 | ||||||||
|
platelet derived growth factor receptor alpha | 0.415 | 0.808 | 1.00 |
|
disease | 0.490 | None | 1.000 | 1 | 5 | 2007 | 2017 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | 0.292 | 0.923 | 1.00 |
|
disease | 0.500 | None | 0.965 | 2 | 1 | 2005 | 2019 | ||||||||
|
phosphatase and tensin homolog | 0.305 | 0.923 | 0.26 |
|
disease | 0.800 | strong | 0.950 | 0 | 3 | 1997 | 2020 | ||||||||
|
Raf-1 proto-oncogene, serine/threonine kinase | 0.418 | 0.885 | 0.85 |
|
disease | 0.500 | None | 1.000 | 1 | 2 | 2002 | 2019 | ||||||||
|
small nuclear RNA activating complex polypeptide 5 | 1.000 | 0.038 | 2.0E-04 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2011 | 2011 | ||||||||
|
serine/threonine kinase 11 | 0.435 | 0.808 | 0.99 |
|
disease | 0.700 | None | 1.000 | 1 | 4 | 1999 | 2018 |